Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  VILLIGER WALTER
 2. Date of Event Requiring Statement (Month/Day/Year)
04/29/2013		 3. Issuer Name and Ticker or Trading Symbol
BIOLIFE SOLUTIONS INC [BLFS]
(Last)
(First)
(Middle)
PARADIESSTRASSE 25		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

CH 8645, JONA, V8 00000		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 400,000
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Series F Preferred Shares (1) 12/31/2001   (1) Common Shares 2,000,000 $ 0 (1) D  
Series F Warrants (1) 12/31/2001 10/31/2006 Common Shares 1,000,000 $ 0.375 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
VILLIGER WALTER
PARADIESSTRASSE 25
CH 8645, JONA, V8 00000		     X    

Signatures

/s/ WALTER VILLIGER 04/29/2013
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) On December 31, 2001, the reporting person participated in a private placement unit offering by the Issuer, purchasing 2,500 Series F units at a purchase price of $200.01 per unit. Each unit consisted of 2 shares of Series F preferred stock, having no expiration date, and 1 Series F purchase warrant. Each share of Series F preferred stock is convertible at any time into 400 shares of common stock of the Issuer. Each Series F warrant is convertible into 400 shares of common stock of the Issuer at $0.375 per share through October 31, 2006. In the event the closing price for the Issuer???s common stock is $0.75 or greater for 10 consecutive trading days, the Series F preferred stock shall automatically be converted into common stock.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.